|
Search
Collections
Benchmarks
Upload document
Product
GP30341
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
3 indications
Indication
pharmacokinetics
Indication
Safety Issues
Indication
efficacy
Clinical trial
Multicenter Open Two-stage Study of Pharmacokinetics, Safety and Efficacy of GP30341, 200 mg Capsules (GEROPHARM LLC, Russia) in Healthy Volunteers and Outpatients With Novel Coronavirus Infection 2019 With a High Risk of Adverse Outcome
Status: Completed
, Estimated PCD: 2022-05-11
